Providing cutting edge antibodies to researchers worldwide
Abcam's catalog http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BnuL0EM
of over 40,000 reagents includes research tools for immunology,
cancer,neuroscience, chromatin, stem cells, cardiovascular
and nuclear signaling.Browse Abcam's immunology range of over
8,800 products,read customer product reviews and
visit the immunology resource centre at
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BnuM0EN
British Journal of Cancer
15 April 2008, Volume 98, Issue 8
Table of Contents
Review
1301 The role of S-1 in the treatment of gastric cancer
T Kubota
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm10Eq
_____________________________________________________________________
Clinical Studies
1305 Phase I/II study of S-1 combined with weekly docetaxel in
patients with metastatic gastric carcinoma
S R Park, H K Kim, C G Kim, I J Choi, J S Lee, J H Lee, K
W Ryu, Y-W Kim, J-M Bae and N K Kim
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm20Er
_____________________________________________________________________
1312 A pharmacokinetic and pharmacodynamic study on metronomic
irinotecan in metastatic colorectal cancer patients
G Allegrini, A Falcone, A Fioravanti, M T Barletta, P
Orlandi, F Loupakis, E Cerri, G Masi, A Di Paolo, R S
Kerbel, R Danesi, M Del Tacca and G Bocci
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm30Es
_____________________________________________________________________
1320 A dose-escalation study of indisulam in combination with
capecitabine (Xeloda) in patients with solid tumours
W S Siegel-Lakhai, A S Zandvliet, A D R Huitema, M M
Tibben, G Milano, V Girre, V Diéras, A King, E Richmond, J
Wanders, J H Beijnen and J H M Schellens
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm40Et
_____________________________________________________________________
1327 A phase II study of sequential neoadjuvant gemcitabine plus
doxorubicin followed by gemcitabine plus cisplatin in
patients with operable breast cancer: prediction of
response using molecular profiling
P K Julka, R T Chacko, S Nag, R Parshad, A Nair, D S Oh, Z
Hu, C B Koppiker, S Nair, R Dawar, N Dhindsa, I D Miller,
D Ma, B Lin, B Awasthy and C M Perou
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm50Eu
_____________________________________________________________________
1336 Vaccination of metastatic renal cell carcinoma patients with
autologous tumour-derived vitespen vaccine: clinical
findings
E Jonasch, C Wood, P Tamboli, L C Pagliaro, S M Tu, J Kim,
P Srivastava, C Perez, L Isakov and N Tannir
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm60Ev
_____________________________________________________________________
1342 Work ability and return-to-work in cancer patients
A G E M de Boer, J H A M Verbeek, E R Spelten, A L J
Uitterhoeve, A C Ansink, T M de Reijke, M Kammeijer, M A G
Sprangers and F J H van Dijk
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm70Ew
_____________________________________________________________________
Translational Therapeutics
1348 Phellinus linteus suppresses growth, angiogenesis and invasive
behaviour of breast cancer cells through the inhibition of
AKT signalling
D Sliva, A Jedinak, J Kawasaki, K Harvey and V Slivova
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0Bsm80Ex
_____________________________________________________________________
1357 Inhibition of ICAM2 induces radiosensitisation in oral squamous
cell carcinoma cells
T Ishigami, K Uzawa, K Fushimi, K Saito, Y Kato, D
Nakashima, M Higo, Y Kouzu, H Bukawa, T Kawata, H Ito and
H Tanzawa
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnA0E8
_____________________________________________________________________
1366 VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits
bevacizumab treatment in experimental colorectal
carcinoma: balance of pro- and antiangiogenic VEGF-A
isoforms has implications for therapy
A H R Varey, E S Rennel, Y Qiu, H S Bevan, R M Perrin, S
Raffy, A R Dixon, C Paraskeva, O Zaccheo, A B Hassan, S J
Harper and D O Bates
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnB0EA
_____________________________________________________________________
1380 The rexinoid, bexarotene, prevents the development of
premalignant lesions in MMTV-erbB2 mice
Y Li, Y Zhang, J Hill, H-T Kim, Q Shen, R P Bissonnette, W
W Lamph and P H Brown
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnC0EB
_____________________________________________________________________
Molecular Diagnostics
1389 CD133 expression is correlated with lymph node metastasis and
vascular endothelial growth factor-C expression in
pancreatic cancer
S Maeda, H Shinchi, H Kurahara, Y Mataki, K Maemura, M
Sato, S Natsugoe, T Aikou and S Takao
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnD0EC
_____________________________________________________________________
1398 ERCC1 mRNA levels and survival of advanced gastric cancer
patients treated with a modified FOLFOX regimen
J Wei, Z Zou, X Qian, Y Ding, L Xie, J J Sanchez, Y Zhao,
J Feng, Y Ling, Y Liu, L Yu, R Rosell and B Liu
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnE0ED
_____________________________________________________________________
1403 Acquisition of biologically relevant gene expression data by
Affymetrix microarray analysis of archival formalin-fixed
paraffin-embedded tumours
K M Linton, Y Hey, E Saunders, M Jeziorska, J Denton, C L
Wilson, R Swindell, S Dibben, C J Miller, S D Pepper, J A
Radford and A J Freemont
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnF0EE
_____________________________________________________________________
1415 An immunohistochemical perspective of PPARbeta and one of its
putative targets PDK1 in normal ovaries, benign and
malignant ovarian tumours
N Ahmed, C Riley and M A Quinn
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnG0EF
_____________________________________________________________________
1425 Gene expression profiling may improve diagnosis in patients
with carcinoma of unknown primary
J Bridgewater, R van Laar, A Floore and L Van'T Veer
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnH0EG
_____________________________________________________________________
Genetics and Genomics
1431 Elimination of wild-type P53 mRNA in glioblastomas showing
heterozygous mutations of P53
M Szybka, I Zawlik, D Kulczycka, E Golanska, E Jesien, D
Kupnicka, R Stawski, S Piaskowski, E Bieniek, M
Zakrzewska, R Kordek, P P Liberski and P Rieske
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnI0EH
_____________________________________________________________________
1434 CASP8 variants D302H and -652 6N ins/del do not influence the
risk of colorectal cancer in the United Kingdom population
A M Pittman, P Broderick, K Sullivan, S Fielding, E Webb,
S Penegar, I Tomlinson and R S Houlston
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnJ0EI
_____________________________________________________________________
1437 Reorganisation of Wnt-response pathways in colorectal
tumorigenesis
G M Caldwell, C E Jones, Y Soon, R Warrack, D G Morton and
G M Matthews
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnK0EJ
_____________________________________________________________________
1443 Tumour-necrosis factor-A polymorphisms and gastric cancer risk:
a meta-analysis
F Gorouhi, F Islami, H Bahrami and F Kamangar
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnL0EK
_____________________________________________________________________
1452 Promoter hypermethylation of FANCF and outcome in advanced
ovarian cancer
S L Lim, P Smith, N Syed, C Coens, H Wong, M van der Burg,
P Szlosarek, T Crook and J A Green
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnM0EL
_____________________________________________________________________
1457 The BOADICEA model of genetic susceptibility to breast and
ovarian cancers: updates and extensions
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo,
S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C
Southey, H Olsson, O Johannsson, A Borg, B Passini, P
Radice, S Manoukian, D M Eccles, N Tang, E Olah, H
Anton-Culver, E Warner, J Lubinski, J Gronwald, B Gorski,
L Tryggvadottir, K Syrjakoski, O-P Kallioniemi, H Eerola,
H Nevanlinna, P D P Pharoah and D F Easton
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnN0EM
_____________________________________________________________________
1467 High level of telomerase RNA gene expression is associated with
chromatin modification, the ALT phenotype and poor
prognosis in liposarcoma
C J Cairney, S F Hoare, M-G Daidone, N Zaffaroni and W N
Keith
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnO0EN
_____________________________________________________________________
1475 Does smoking among friends explain apparent genetic effects on
current smoking in adolescence and young adulthood?
V M White, G B Byrnes, B Webster and J L Hopper
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnP0EO
_____________________________________________________________________
Letters to the Editor
1482 Early onset breast cancer in black British women: a letter to
the editor of British Journal of Cancer regarding early
onset of breast cancer in a group of British black women
S Dindyal, M J Ramdass and V Naraynsingh
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnQ0EP
_____________________________________________________________________
1483 Reply: Early onset breast cancer in black British women: a
letter to the editor of British Journal of Cancer
regarding early onset of breast cancer in a group of
British black women
R Bowen, S Duffy, D Ryan, I Hart and L Jones
http://ealerts.nature.com/cgi-bin24/DM/y/ekJ40Xztnp0Hhi0BsnR0EQ
_____________________________________________________________________
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
